Shi Heidi Y, Stafford Lewis Joe, Liu Zhisheng, Liu Mingyao, Zhang Ming
Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.
Cell Motil Cytoskeleton. 2007 May;64(5):338-46. doi: 10.1002/cm.20187.
Rac1 and Cdc42 are members of the Rho family of small GTPases that play essential roles in diverse cellular functions, including cell migration. The activities of these Rho family proteins are controlled by growth factor receptor activation and cell-ECM interactions. Here, we show that maspin, a well-documented tumor suppressor gene, also controls cell motility through inhibiting Rac1/Cdc42 activity. Using the GST-PAK and GST-Rho binding protein pull-down assays for GTP-bound Rac1, Cdc42, and RhoA, we showed that treatment of MDA-MB-231 tumor cells with recombinant maspin for a short time period significantly inhibited the activity of Rac1 and Cdc42, but not RhoA. The reactive site loop (RSL) within maspin protein is the functional domain involved in the inhibition. Maspin mutants with the RSL deleted or a point mutation in the RSL region lost their inhibitory activity. We further examined the ability of maspin to inhibit Rac1- and Cdc42-mediated signaling pathways and transcription factors. Treatment of MDA-MB-231 cells with maspin led to the inhibition of JNK kinase activity as assayed by immuno-kinase assays. In addition, the AP-1 transcription activity downstream of JNK kinase pathway was also reduced. Together, we have identified Rac1 and Cdc42 as the downstream targets that mediate the inhibition of mammary tumor cell migration by maspin.
Rac1和Cdc42是小GTP酶Rho家族的成员,在包括细胞迁移在内的多种细胞功能中发挥着重要作用。这些Rho家族蛋白的活性受生长因子受体激活和细胞与细胞外基质相互作用的控制。在此,我们表明,maspin是一个有充分文献记载的肿瘤抑制基因,它也通过抑制Rac1/Cdc42的活性来控制细胞运动。使用针对结合GTP的Rac1、Cdc42和RhoA的GST-PAK和GST-Rho结合蛋白下拉实验,我们发现用重组maspin短时间处理MDA-MB-231肿瘤细胞可显著抑制Rac1和Cdc42的活性,但不影响RhoA的活性。maspin蛋白内的反应位点环(RSL)是参与抑制作用的功能域。缺失RSL或RSL区域存在点突变的maspin突变体失去了其抑制活性。我们进一步研究了maspin抑制Rac1和Cdc42介导的信号通路及转录因子的能力。用maspin处理MDA-MB-231细胞导致通过免疫激酶实验检测到的JNK激酶活性受到抑制。此外,JNK激酶通路下游的AP-1转录活性也降低。总之,我们已确定Rac1和Cdc42是介导maspin对乳腺肿瘤细胞迁移抑制作用的下游靶点。